147 related articles for article (PubMed ID: 8380685)
21. Use of isotopic immunoglobulin in therapy.
Order SE; Klein JL; Ettinger D; Alderson P; Siegelman S; Leichner P
Cancer Res; 1980 Aug; 40(8 Pt 2):3001-7. PubMed ID: 6249495
[TBL] [Abstract][Full Text] [Related]
22. [Radiotherapy of malignant tumors of the liver].
Ducreux M; Lartigau E; Eschwege F; Etienne JP
Gastroenterol Clin Biol; 1995 Apr; 19(4):350-60. PubMed ID: 7672521
[No Abstract] [Full Text] [Related]
23. The 131I antiferritin breakthrough.
Moertel CG
J Clin Oncol; 1986 Apr; 4(4):608-9. PubMed ID: 3958772
[No Abstract] [Full Text] [Related]
24. Distribution of monoclonal antiferritin antibody in Kaposi's sarcoma, Hodgkin's disease, and hepatocellular carcinoma.
Yuen AR; Higgins JP; Baker R; Kamel OW; Warnke RA; Knox SJ
Hum Pathol; 2003 Apr; 34(4):381-4. PubMed ID: 12733120
[TBL] [Abstract][Full Text] [Related]
25. Phase I-II study of radiolabeled antibody integrated in the treatment of primary hepatic malignancies.
Order SE; Klein JL; Ettinger D; Alderson P; Siegelman S; Leichner P
Int J Radiat Oncol Biol Phys; 1980 Jun; 6(6):703-10. PubMed ID: 6256319
[No Abstract] [Full Text] [Related]
26. Regional radioactive treatments for hepatocellular carcinoma.
Gonsalves CF; Brown DB; Carr BI
Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):453-6. PubMed ID: 19072393
[No Abstract] [Full Text] [Related]
27. Radiolabeled antibody in the treatment of primary and metastatic liver malignancies.
Order SE; Klein JL; Leichner PK; Ettinger DS; Kopher K; Finney K; Surdyke M; Leibel SA
Recent Results Cancer Res; 1986; 100():307-14. PubMed ID: 3016844
[No Abstract] [Full Text] [Related]
28. [Proton radiation therapy of non-resectable liver neoplasm].
Matsuzaki Y; Osuga T; Tanaka N; Tsujii H
Nihon Naika Gakkai Zasshi; 1994 Sep; 83(9):1566-9. PubMed ID: 7798751
[No Abstract] [Full Text] [Related]
29. Radioimmunotherapy for hepatocellular carcinoma (HCC) using 131I-anti HCC isoferritin IgG: preliminary results of experimental and clinical studies.
Liu KD; Tang ZY; Bao YM; Lu JZ; Qian F; Yuan AN; Zhao HY
Int J Radiat Oncol Biol Phys; 1989 Feb; 16(2):319-23. PubMed ID: 2537805
[TBL] [Abstract][Full Text] [Related]
30. Radioimmunotherapy of colon carcinoma with I-131 labeled antibodies, successful experimental results and clinical dosimetry study.
Mach JP; Buchegger F; Pelegrin A; Ychou M; Ricard M; Lumbroso J; Rougier P; Lasser P; Elias D; Saccavini JC
Pathol Biol (Paris); 1990 Oct; 38(8):819. PubMed ID: 2274371
[No Abstract] [Full Text] [Related]
31. Combined therapy with external beam irradiation and hepatic arterial epirubicin infusion through an implanted port for advanced hepatocellular carcinoma.
Takizawa K; Honda M; Obuchi M; Hasebe S; Matsuoka S; Yamada M; Kuniyasu Y
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-116-S6-121. PubMed ID: 9151926
[TBL] [Abstract][Full Text] [Related]
32. A randomized prospective trial comparing full dose chemotherapy to 131I antiferritin: an RTOG study.
Order S; Pajak T; Leibel S; Asbell S; Leichner P; Ettinger D; Stillwagon G; Herpst J; Haulk T; Kopher K
Int J Radiat Oncol Biol Phys; 1991 May; 20(5):953-63. PubMed ID: 1850722
[TBL] [Abstract][Full Text] [Related]
33. In vitro demonstration of synergy between radionuclide and chemotherapy.
Chenoufi N; Raoul JL; Lescoat G; Brissot P; Bourguet P
J Nucl Med; 1998 May; 39(5):900-3. PubMed ID: 9591598
[TBL] [Abstract][Full Text] [Related]
34. Preoperative treatment of hepatocellular carcinoma with intra-arterial injection of 131I-labelled lipiodol (Br J Surg 2003; 90: 1379-1383).
Rai R; Rai S
Br J Surg; 2004 Mar; 91(3):373; author reply 373. PubMed ID: 14991642
[No Abstract] [Full Text] [Related]
35. 90Yttrium antiferritin--a new therapeutic radiolabeled antibody.
Order SE; Klein JL; Leichner PK; Frincke J; Lollo C; Carlo DJ
Int J Radiat Oncol Biol Phys; 1986 Feb; 12(2):277-81. PubMed ID: 3005201
[TBL] [Abstract][Full Text] [Related]
36. Dosimetry of 131I-labeled anti-ferritin in hepatoma: a model for radioimmunoglobulin dosimetry.
Leichner PK; Klein JL; Garrison JB; Jenkins RE; Nickoloff EL; Ettinger DS; Order SE
Int J Radiat Oncol Biol Phys; 1981 Mar; 7(3):323-33. PubMed ID: 6268576
[No Abstract] [Full Text] [Related]
37. 131-iodine Lipiodol therapy in hepatocellular carcinoma.
Raoul JL; Boucher E; Roland V; Garin E
Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):348-55. PubMed ID: 19521315
[TBL] [Abstract][Full Text] [Related]
38. Benefits of combined radioimmunotherapy and anti-angiogenic therapy in a liver metastasis model of human colon cancer cells.
Li XF; Kinuya S; Yokoyama K; Koshida K; Mori H; Shiba K; Watanabe N; Shuke N; Michigishi T; Tonami N
Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1669-74. PubMed ID: 12458402
[TBL] [Abstract][Full Text] [Related]
39. Doxorubicin-conjugated anti-midkine monoclonal antibody as a potential anti-tumor drug.
Inoh K; Muramatsu H; Torii S; Ikematsu S; Oda M; Kumai H; Sakuma S; Inui T; Kimura T; Muramatsu T
Jpn J Clin Oncol; 2006 Apr; 36(4):207-11. PubMed ID: 16611663
[TBL] [Abstract][Full Text] [Related]
40. [Biological distribution of 131I-HAb18F(ab')2 in patients with hepatocellular carcinoma].
Lu W; Li X; Wang C; Liu W; Jiao H; Mo T; Chen Z
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Dec; 20(4):689-91. PubMed ID: 14716878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
